UBS AM’s Foundation Medicine, Inc. FMI Stock Holding History

UBS AM’s Portfolio FMI Stock Details FMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-11,939	Closed	-$1.63M	–	2853
2018 Q2	$1.63M	Buy	11,939 +4,247	+55%	+$386K	﹤0.01%	1593
2018 Q1	$606K	Buy	7,692 +4,157	+118%	+$307K	﹤0.01%	1955
2017 Q4	$241K	Buy	+3,535	New	+$183K	﹤0.01%	2213
2015 Q3	–	Sell	-7,078	Closed	-$240K	–	2713
2015 Q2	$240K	Sell	7,078 -1,122	-14%	-$45.1K	﹤0.01%	2500
2015 Q1	$395K	Buy	+8,200	New	+$372K	﹤0.01%	2108
2014 Q3	–	Sell	-8,200	Closed	-$221K	–	2590
2014 Q2	$221K	Buy	+8,200	New	+$208K	﹤0.01%	2364

UBS AM's FMI Position: Q3 2018 in Review

UBS AM sold out of Foundation Medicine, Inc. (FMI) in Q3 2018, closing a stake of 11,939 shares — an estimated $1.63M sold.

UBS AM first reported a position in FMI in Q2 2014 and held it in 6 quarters. The position peaked at $1.63M in Q2 2018. 0 funds tracked by Wall St. Rank hold FMI as of Q3 2018.

UBS AM reported no remaining Foundation Medicine, Inc. position as of Q3 2018 after selling out during the quarter.
UBS AM sold 11,939 Foundation Medicine, Inc. shares in Q3 2018, an estimated $1.63M.
UBS AM first reported a position in Foundation Medicine, Inc. in Q2 2014 and held it in 6 quarters.
UBS AM's Foundation Medicine, Inc. position peaked at $1.63M in Q2 2018.
0 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2018.

Based on UBS AM's 13F filing for Q3 2018, filed 14 Nov 2018.